🇺🇸 FDA
Patent

US 10363292

Vaccination with anti-tick antigens to control multiple tick species and disease transmission in white-tailed deer and other host animals

granted A61KA61K2039/53A61K2039/552

Quick answer

US patent 10363292 (Vaccination with anti-tick antigens to control multiple tick species and disease transmission in white-tailed deer and other host animals) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/53, A61K2039/552, A61K2039/55566, A61K2039/58